Literature DB >> 6834470

Cycloheximide stimulates early adenovirus transcription if early gene expression is allowed before treatment.

F R Cross, J E Darnell.   

Abstract

The inhibition of protein synthesis by cycloheximide markedly stimulated adenovirus 2 early transcription (assayed in vivo and in vitro in nuclei) when the drug was added 3 h after infection of HeLa cells. The stimulation was not uniform but ranged from three- to eightfold for region 1A to 10- to 30-fold for region 2 of the adenovirus genome. The increase was complete by about 60 min after treatment. The stimulation reversed rapidly after cycloheximide was removed. Treatment with cycloheximide either before infection with wild-type adenovirus type 5 or at 3 h after infection with dl312, a mutant which fails to express early gene products in HeLa cells, both resulted in levels of transcription at or substantially below the control (infection with wild-type adenovirus without treatment). Therefore we conclude that cycloheximide treatment and previous early gene expression interact to yield the maximum levels of transcription.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6834470      PMCID: PMC256463     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The initiation sites for RNA transcription in Ad2 DNA.

Authors:  R M Evans; N Fraser; E Ziff; J Weber; M Wilson; J E Darnell
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  The definition of a large viral transcription unit late in Ad2 infection of HeLa cells: mapping of nascent RNA molecules labeled in isolated nuclei.

Authors:  J Weber; W Jelinek; J E Darnell
Journal:  Cell       Date:  1977-04       Impact factor: 41.582

4.  Effect of cycloheximide on RNA metabolism early in productive infection with adenovirus 2.

Authors:  E A Craig; H J Raskas
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

5.  Biochemical studies on adenovirus multiplication. 18. Resolution of early virus-specific RNA species in Ad 2 infected and transformed cells.

Authors:  J T Parsons; M Green
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

6.  Steps in the processing of Ad2 mRNA: poly(A)+ nuclear sequences are conserved and poly(A) addition precedes splicing.

Authors:  J R Nevins; J E Darnell
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

7.  Regulation of an early RNA transcribed from the transforming segment of the adenovirus 2 genome.

Authors:  F Eggerding; H J Raskas
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

8.  Effect of protein synthesis inhibitors on viral mRNA's synthesized early in adenovirus type 2 infection.

Authors:  F Eggerding; H J Raskas
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

9.  Adenovirus type 2 mRNA in transformed cells: map positions and difference in transport time.

Authors:  M C Wilson; S G Sawicki; M Salditt-Georgieff; J E Darnell
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

10.  Structure of the adenovirus 2 early mRNAs.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

View more
  22 in total

Review 1.  Viral and cellular interactions during adenovirus DNA replication.

Authors:  Matthew Charman; Christin Herrmann; Matthew D Weitzman
Journal:  FEBS Lett       Date:  2019-12-17       Impact factor: 4.124

2.  Posttranscriptional control of human gamma interferon gene expression in transfected mouse fibroblasts.

Authors:  H A Young; L Varesio; P Hwu
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

3.  In vivo splicing of the premRNAs from early region 3 of adenovirus-2: the products of cleavage at the 5' splice site of the common intron.

Authors:  A Sittler; H Gallinaro; M Jacob
Journal:  Nucleic Acids Res       Date:  1986-02-11       Impact factor: 16.971

4.  Control of adenovirus early gene expression during the late phase of infection.

Authors:  S P Fessler; C S Young
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  A labile inhibitor blocks immunoglobulin kappa-light-chain-gene transcription in a pre-B leukemic cell line.

Authors:  R Wall; M Briskin; C Carter; H Govan; A Taylor; P Kincade
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

6.  Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression.

Authors:  J M Friedman; L E Babiss; D F Clayton; J E Darnell
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

7.  Transcription unit mapping in adenovirus: regions of termination.

Authors:  S Iwamoto; F Eggerding; E Falck-Pederson; J E Darnell
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

8.  Far upstream sequences are required for efficient transcription from the adenovirus-2 E1A transcription unit.

Authors:  P Sassone-Corsi; R Hen; E Borrelli; T Leff; P Chambon
Journal:  Nucleic Acids Res       Date:  1983-12-20       Impact factor: 16.971

9.  Inhibition of protein synthesis in LLC-PK1 cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability.

Authors:  M S Altus; D Pearson; A Horiuchi; Y Nagamine
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

10.  The different intron 2 species excised in vivo from the E2A premRNA of adenovirus-2: an approach to analyse alternative splicing.

Authors:  P Keohavong; R Gattoni; P Schmitt; J Stévenin
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.